These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 18688699
1. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. Banchs JE, Wolbrette DL, Samii SM, Penny-Peterson ED, Patel PP, Young SK, Gonzalez MD, Naccarelli GV. J Interv Card Electrophysiol; 2008 Nov; 23(2):111-5. PubMed ID: 18688699 [Abstract] [Full Text] [Related]
2. Dofetilide: a review of its use in atrial fibrillation and atrial flutter. McClellan KJ, Markham A. Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390 [Abstract] [Full Text] [Related]
3. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD. Congenit Heart Dis; 2014 Dec; 9(3):221-7. PubMed ID: 23947935 [Abstract] [Full Text] [Related]
4. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB. Circulation; 2000 Nov 07; 102(19):2385-90. PubMed ID: 11067793 [Abstract] [Full Text] [Related]
5. Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival. Khurshid S, Akerman S, Man JP, Supple G, Dixit S, Epstein AE, Marchlinski FE, Frankel DS. J Interv Card Electrophysiol; 2015 Mar 07; 42(2):117-24. PubMed ID: 25620152 [Abstract] [Full Text] [Related]
6. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. Nørgaard BL, Wachtell K, Christensen PD, Madsen B, Johansen JB, Christiansen EH, Graff O, Simonsen EH. Am Heart J; 1999 Jun 07; 137(6):1062-9. PubMed ID: 10347332 [Abstract] [Full Text] [Related]
7. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Coleman CI, Sood N, Chawla D, Talati R, Ghatak A, Kluger J, Dofetilide and Intravenous Magnesium Evaluation (DIME) Investigators. Europace; 2009 Jul 07; 11(7):892-5. PubMed ID: 19351630 [Abstract] [Full Text] [Related]
8. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp-Pedersen C. Circulation; 2001 Jul 17; 104(3):292-6. PubMed ID: 11457747 [Abstract] [Full Text] [Related]
9. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter]. Vergara G. Ital Heart J Suppl; 2001 Mar 17; 2(3):322-3. PubMed ID: 11307794 [No Abstract] [Full Text] [Related]
10. Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy. Malhotra R, Bilchick KC, DiMarco JP. Am J Cardiol; 2014 Feb 01; 113(3):475-9. PubMed ID: 24321897 [Abstract] [Full Text] [Related]
11. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. Bianconi L, Castro A, Dinelli M, Alboni P, Pappalardo A, Richiardi E, Santini M. Eur Heart J; 2000 Aug 01; 21(15):1265-73. PubMed ID: 10924317 [Abstract] [Full Text] [Related]
12. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. Falk RH, Pollak A, Singh SN, Friedrich T. J Am Coll Cardiol; 1997 Feb 01; 29(2):385-90. PubMed ID: 9014993 [Abstract] [Full Text] [Related]
13. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J. Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638 [Abstract] [Full Text] [Related]
17. Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation. Steinberg JS, Shah Y, Szepietowska B. Pacing Clin Electrophysiol; 2017 Jun 20; 40(6):667-671. PubMed ID: 28220940 [Abstract] [Full Text] [Related]